Screening asymptomatic men for prostate cancer: A comparison of international guidelines on prostate-specific antigen testing.

ABSTRACT:

Objective

To summarise and compare the key recommendations on prostate-specific antigen (PSA)-based screening for prostate cancer, and so highlight where more evidence is required to facilitate consistent recommendations.

Methods

The Medline database and websites of 18 national screening organisations and professional associations were searched between January 2010 and November 2020 to identify screening guidelines published in English, considering recent clinical trials.

Results

Population-based PSA testing of asymptomatic men is not widely recommended. Guidelines emphasize shared patient-clinician decision making. For 'average-risk' men choosing to be screened, the recommended age varies from 50-55 to 70 years, alongside consideration of life expectancy (ranging fro

SUBMITTER: Jackson SD 

PROVIDER: S-EPMC9574423 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature